Bioxodes is a clinical-stage biotech company developing therapeutics for patients with (thrombo)inflammatory diseases.
Gosselies, Belgium
Joined June 2019
- Tweets46
- Following122
- Followers60
- Likes111
Bioxodes SA retweeted
@bioxodes receives European Patent Office intention to grant patent, offering lead asset broad protection in thromboinflammation. tinyurl.com/35ch8vwu
Bioxodes SA retweeted
[ALA Client News] @bioxodes presents latest developments at key international conferences - on first-in-class drug candidate for patients with intracerebral hemorrhage
👉ala.associates/events/bioxod…
@BioCentury @ESOstroke @isth
#conferences #BioEquity2023 #ESOC2023 #ISTH2023
Bioxodes SA retweeted
[ALA Client News] @bioxodes appoints Marc Dechamps as new CEO
ala.com/appointment/bioxodes…
#hemorrhage #inflammatorydiseases #appointments
Bioxodes SA retweeted
Marc Dechamps prend la tête de @bioxodes, une société wallonne qui développe un traitement contre les hémorragies intracérébrales au départ d'une molécule prélevée dans la salive des tiques.
➡ lecho.be/entreprises/pharma-…?
✍️ Par @GossetOlivier1 |
#entreprises #biotech #Wallonie
Bioxodes SA retweeted
New review: It is challenging to prevent medical device-associated
#thrombosis 💊 without 🔼#bleeding risk. Demoulin et al
@BioxodesSA @HermansCedric discuss why inhibitors #coagulation FXII or FXI are promising alternatives.
bit.ly/2H9CDnc
Bioxodes SA retweeted
Novel anticoagulant Ir-CPI might be a safer choice in cardiopulmonary bypass compared to herparin suggests new #JACC research: fal.cn/34J03
Bioxodes SA retweeted
It is possible to perform cardiopulmonary bypass surgery in sheep with the just recombinant tick anticoagulant (Ir-CPI). It is as good as heparin but causes less bleeding. Another plus for contact inhibition as the next group of anticoagulants. tiny.cc/in38ez
Bioxodes SA retweeted
Ir-CPI, a specific inhibitor of both FXIIa and FXIa, could provide a safe and efficient alternative to prevent thrombus formation in cardiopulmonary bypass. fal.cn/34FW1 #JACC #cvCoag
Bioxodes SA retweeted
Another great poster 0051. They show that a FXIa/FXIIa inhibitor from the saliva of the tick l.ricinus is as good as UFH in inhibiting thrombosis in a sheep cardiac surgery model looking forward to the human studies. #ISTH2019
